Firefly Neuroscience, Inc.
AIFF
$4.25
$0.7922.83%
Weiss Ratings | AIFF - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D- | |||
Reward Grade | E | |||
Rating Factors | AIFF - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Good | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | AIFF - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | -- | |||
Price History | AIFF - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 9.54% | |||
30-Day Total Return | 29.18% | |||
60-Day Total Return | 44.07% | |||
90-Day Total Return | 41.20% | |||
Year to Date Total Return | 66.02% | |||
1-Year Total Return | -- | |||
2-Year Total Return | -- | |||
3-Year Total Return | -- | |||
5-Year Total Return | -- | |||
52-Week High % Change | -75.29% | |||
52-Week Low % Change | 128.49% | |||
Price | AIFF - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $17.20 | |||
52-Week Low Price | $1.86 | |||
52-Week Low Price (Date) | Jan 13, 2025 | |||
52-Week High Price (Date) | Feb 13, 2025 | |||
Valuation | AIFF - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 34.30M | |||
Enterprise Value | 33.07M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.68 | |||
Earnings Per Share Growth | 19.25% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 408.65 | |||
Price/Book (Q) | 12.98 | |||
Enterprise Value/Revenue (TTM) | 446.95 | |||
Price | $4.25 | |||
Enterprise Value/EBITDA (TTM) | -4.67 | |||
Enterprise Value/EBIT | -4.04 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | AIFF - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 7.08M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | AIFF - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 888-237-6412 | |||
Address | 150 King St W Toronto, ON M5H 1J9 | |||
Website | fireflyneuro.com | |||
Country | Canada | |||
Year Founded | -- | |||
Profitability | AIFF - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -11,060.81% | |||
Profit Margin | -10,475.67% | |||
Management Effectiveness | AIFF - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -162.14% | |||
Return on Equity | -- | |||
Income Statement | AIFF - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 74.00K | |||
Total Revenue (TTM) | 74.00K | |||
Revenue Per Share | $0.01 | |||
Gross Profit (TTM) | 74.00K | |||
EBITDA (TTM) | -7.08M | |||
EBIT (TTM) | -8.19M | |||
Net Income (TTM) | -7.75M | |||
Net Income Avl. to Common (TTM) | -7.75M | |||
Total Revenue Growth (Q YOY) | 43.48% | |||
Earnings Growth (Q YOY) | -559.85% | |||
EPS Diluted (TTM) | -0.68 | |||
EPS Diluted Growth (Q YOY) | -242.78% | |||
Balance Sheet | AIFF - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 1.23M | |||
Cash Per Share (Q) | $0.17 | |||
Total Current Assets (Q) | 2.67M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 2.78M | |||
Current Ratio (Q) | 1.051 | |||
Book Value Per Share (Q) | $0.33 | |||
Total Assets (Q) | 5.31M | |||
Total Current Liabilities (Q) | 2.54M | |||
Total Debt (Q) | 0.00 | |||
Total Liabilities (Q) | 2.54M | |||
Total Common Equity (Q) | 2.78M | |||
Cash Flow | AIFF - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -787.00K | |||
Cash from Financing (TTM) | 6.57M | |||
Net Change in Cash (TTM) | 337.00K | |||
Levered Free Cash Flow (TTM) | -3.34M | |||
Cash from Operations (TTM) | -5.45M | |||